MoonLake Immunotherapeutics (MLTX) Ownership - Who owns MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLTX showed earnings on August 05, 2025. You can read more about the earnings report here.